🎁 Black Friday: up to 50% off of annual plans
AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
5.08
-0.14 (-2.68%)
At close: Nov 20, 2026, 4:00 PM EST
5.10
+0.02 (0.39%)
After-hours: Nov 20, 2026, 7:30 PM EST

AN2 Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
20.2119.9421.3515.6527.2212.1
Short-Term Investments
44.1938.0662.2791.6568.8446.46
Cash & Short-Term Investments
64.45883.62107.396.0658.56
Cash Growth
4.00%-30.64%-22.07%11.70%64.05%1338.70%
Other Receivables
0.70.90.31.4--
Receivables
0.70.90.31.4--
Prepaid Expenses
0.661.042.341.812.511.55
Other Current Assets
----0.05-
Total Current Assets
65.7659.9486.26110.5198.6260.11
Long-Term Investments
15.82.015.0227.193.223.49
Long-Term Deferred Charges
-----1.72
Other Long-Term Assets
0.39-0.81.040.72-
Total Assets
81.9661.9592.09138.74102.5665.32

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
1.663.023.322.682.121.06
Accrued Expenses
3.674.476.1310.75.012
Current Portion of Leases
----0.05-
Other Current Liabilities
0.951.230.790.670.010.33
Total Current Liabilities
6.288.7210.2414.047.193.4
Other Long-Term Liabilities
0.170.17--00.01
Total Liabilities
6.458.8910.2414.047.193.41

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Additional Paid-In Capital
342.84293.95287.59278.88185.47-
Retained Earnings
-267.12-240.95-205.78-154.46-89.72-47.38
Comprehensive Income & Other
-0.210.060.030.28-0.37-0.03
Total Common Equity
75.5153.0681.85124.795.37-47.41
Shareholders' Equity
75.5153.0681.85124.795.3761.91
Total Liabilities & Equity
81.9661.9592.09138.74102.5665.32

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
----0.05-
Net Cash (Debt)
64.45883.62107.396.0158.56
Net Cash Growth
4.00%-30.64%-22.07%11.76%63.96%1338.70%
Net Cash Per Share
1.661.922.804.556.2622.20
Filing Date Shares Outstanding
37.9435.9430.129.7719.42.73
Total Common Shares Outstanding
37.8927.4129.9229.7419.42.73
Working Capital
59.4951.2276.0296.4691.4456.71
Book Value Per Share
1.991.942.744.194.92-17.36
Tangible Book Value
75.5153.0681.85124.795.37-47.41
Tangible Book Value Per Share
1.991.942.744.194.92-17.36
SEC Filings: 10-K · 10-Q